Home / Guides / Does tirzepatide make you tired?

How often. Why. What helps.

Does tirzepatide make you tired? How often, why, and what helps

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

Sometimes: in SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 5% to 7% of people on Zepbound reported fatigue, versus 3% on placebo, its August 2026 label says. It rose with the dose; eating less, losing fluids and, with some diabetes medicines, low blood sugar can add to it; compounded tirzepatide wasn’t studied.

  • Side effects peak: early on and after each dose increase
  • Check first: food, fluids and, with diabetes, your blood sugar
  • Get help fast: call 911 for confusion or fainting

Tiredness on tirzepatide, in short

How often
5% to 7% on Zepbound vs 3% on placebo, more at higher doses (SURMOUNT-1, 2022, and SURMOUNT-2, 2023)
When
Side effects are likeliest early on and after each dose increase
Check
Food, fluids and, on insulin or a sulfonylurea, your blood sugar
Get help fast
911 for confusion or fainting; your provider if fluids won’t stay down
Compounded tirzepatide
Not studied in Zepbound’s trials

Feeling run down on your medicine? Call or text (949) 818-8000. Real people answer 24/7.

Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.

The short version

Tirzepatide fatigue at a glance: how often, by dose and how long

Tirzepatide and tiredness at a glance: how often people on Zepbound reported fatigue, by dose, what the label counts as fatigue, Mounjaro, how long it lasts and compounded tirzepatide
QuestionAnswer
How often?5% to 7% on Zepbound reported fatigue, versus 3% on placebo (SURMOUNT-1, 2022, and SURMOUNT-2, 2023)
Does the dose matter?A little: 5% on 5 mg, 6% on 10 mg and 7% on 15 mg
What counts as fatigue?Weakness (asthenia), fatigue, lethargy and malaise, on Zepbound’s label
And Mounjaro?10% in SURPASS-CVOT (2025), a heart trial with no placebo group
How long does it last?No label says. Side effects tend to ease on a steady dose, a 2025 advisory says.
Compounded tirzepatide?Not studied in these trials, and not FDA-approved
  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • Sometimes. In Zepbound’s trials, 5% to 7% reported fatigue, versus 3% on placebo; compounded tirzepatide wasn’t studied.
  • It rose a little with the dose: 5% on 5 mg, 6% on 10 mg and 7% on 15 mg.
  • No label times fatigue itself. Side effects in general peak early and after each increase, then ease, a 2025 advisory says.
  • Several causes can be checked: eating far less, losing fluids and, with insulin or a sulfonylurea, low blood sugar.
  • Get help fast: 911 for confusion or fainting; your provider if fluids won’t stay down.
  • At NexLife, holding or lowering a dose doesn’t change the price: $115 a month on the 12-month plan.

At a glance

What do the tirzepatide labels say about fatigue?

Zepbound’s label counts it by dose; Mounjaro’s lists it for one trial. Here are the label facts side by side.

From the Zepbound and Mounjaro prescribing information (both revised August 2026), read November 1, 2026. Percentages are against placebo unless noted. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.
ZepboundMounjaroCompounded tirzepatide
Made byEli LillyEli LillyPrepared by a state-licensed pharmacy for one patient
FDA-approved forAdults: weight reduction and upkeep, and moderate to severe sleep apnea with obesityType 2 diabetes from age 10, and cutting heart risks in high-risk adults with itNot FDA-approved
Dose stepsStarts at 2.5 mg a week; up 2.5 mg after at least 4 weeks; 5 to 15 mg to stay onStarts at 2.5 mg a week; up 2.5 mg after at least 4 weeks; at most 15 mgSet by your prescription
Fatigue reported5% to 7% by dose, vs 3% on placebo (SURMOUNT-1, 2022, and SURMOUNT-2, 2023)Not among side effects in 5% or more in its placebo trials; 10% in SURPASS-CVOT (2025), which had no placeboNot studied
What counts as fatigueWeakness (asthenia), fatigue, lethargy and malaiseNot broken downNo FDA label
Low blood sugarglucose below 54 mg/dL4.2% vs 1.3% in type 2 diabetes (SURMOUNT-2)14% to 19% vs 13% with basal insulin (SURPASS-5, 2022)Not studied
Half-life5 to 6 daysAbout 5 daysNo FDA label

Swipe the table sideways to see every column.

From the Zepbound and Mounjaro prescribing information (both revised August 2026), read November 1, 2026. Percentages are against placebo unless noted. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.

Your situation

Tired on tirzepatide? Start with your situation

The likely reason depends on where you are in treatment and what else you take. Your provider decides any change to your dose.

  • Your dose just went up

    Side effects bunch up in the first weeks and after each increase, then tend to ease on a steady dose, a 2025 advisory says. If tiredness lingers at a step, tell your provider before the next one.

  • You take insulin or a sulfonylurea

    Weakness or feeling tired can be a sign of low blood sugar, so check your level when you feel off. Tirzepatide makes lows likelier with these medicines, and your provider may lower their doses.

  • You’re barely eating

    Below about 1,200 calories a day for women or 1,800 for men, vitamins and minerals can fall short, a 2025 advisory says. Tiredness beyond what you’d expect can signal a shortfall.

  • You’re vomiting or have diarrhea

    Both drain fluids, and dehydration can bring dizziness and listlessness, MedlinePlus says. Zepbound’s patient guide says to drink fluids and tell your provider right away if they don’t go away.

  • You take blood pressure medicine

    In SURMOUNT-1 (2022) and SURMOUNT-2 (2023), low blood pressure was more common on Zepbound in people also on blood pressure medicines. If you feel dizzy or lightheaded, tell your provider.

  • You also feel low or flat

    The FDA found no increased risk of suicidal thoughts with GLP-1 medicines, but asks you to tell your health care professional about new or worsening depression. In distress, call or text 988.

These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied. Your provider decides any change to tirzepatide or your other medicines.

How common

How common is fatigue on tirzepatide?

A minority of people report it. In SURMOUNT-1 (2022) and SURMOUNT-2 (2023), fatigue rose a little with each dose, from 5% on 5 mg to 7% on 15 mg, versus 3% on placebo; compounded tirzepatide wasn’t studied.

Zepbound prescribing information (revised August 2026), Table 1: SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 72 weeks each, pooled. The label counts weakness (asthenia), fatigue, lethargy and malaise as fatigue. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
GroupPeopleReported fatigueMore than placebo
Placebo9583%—
Zepbound 5 mg6305%2 more in 100
Zepbound 10 mg9486%3 more in 100
Zepbound 15 mg9417%4 more in 100

Swipe the table sideways to see every column.

Zepbound prescribing information (revised August 2026), Table 1: SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 72 weeks each, pooled. The label counts weakness (asthenia), fatigue, lethargy and malaise as fatigue. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.

In plain numbers. On 15 mg, about 7 in 100 people reported fatigue, against about 3 in 100 on placebo: 4 more in every 100. So most people in the trials didn’t report it.

Mounjaro. Its table of side effects reported by 5% or more in its placebo-controlled diabetes trials (SURPASS-1, 2021, and SURPASS-5, 2022) doesn’t include fatigue. In SURPASS-CVOT (2025), a heart-outcomes trial of 6,647 adults on Mounjaro with type 2 diabetes and heart disease, the label lists fatigue in 10%. That trial compared Mounjaro with dulaglutide and had no placebo group, so it can’t show how much of the 10% came from the drug. Dulaglutide is Trulicity; the two are compared trial by trial in Trulicity vs. tirzepatide. Neither trial studied compounded tirzepatide.

The patient guide. Zepbound’s Medication Guide lists “feeling tired” among its most common side effects, with nausea, diarrhea and constipation. More: every common tirzepatide side effect.

How long

When does tirzepatide fatigue start, and how long does it last?

The labels don’t say when fatigue starts or stops. They do show when side effects cluster: while the dose is rising, in steps at least 4 weeks apart.

  1. Treatment starts at 2.5 mg once a week, on both Zepbound’s and Mounjaro’s labels.

  2. The dose can rise by 2.5 mg, no sooner than 4 weeks after the last step. Reaching 15 mg takes at least 20 weeks.

  3. In SURMOUNT-1 (2022) and SURMOUNT-2 (2023), most nausea, vomiting and diarrhea came during dose increases and eased over time. Compounded tirzepatide wasn’t studied.

  4. Side effects tend to come less often and less strongly once the dose holds, a 2025 advisory from four medical and nutrition societies says.

  5. Tirzepatide’s half-life is 5 to 6 days on Zepbound’s label: about half a dose is gone 5 to 6 days later, which is why it’s a weekly shot.

How long is too long? No label sets a number. If tiredness doesn’t ease after a few weeks on the same dose, or it gets in the way of your day, tell your provider. They decide whether to hold a step or lower your dose; Zepbound’s label says a lower maintenance dose can be considered if one isn’t tolerated.

“If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026, section 2.1

More on the dose steps: the tirzepatide timeline, month by month and your dose in units.

Why

Why am I so tired on tirzepatide?

Several reasons can stack up, and most can be checked. These are the ones the labels and a 2025 nutrition advisory point to.

  • Much less food

    GLP-1 medicines cut how much people eat by 16% to 39% compared with placebo, the advisory says. Tiredness beyond what you’d expect can be a sign of a nutrient shortfall.

  • Too few fluids

    Nausea, vomiting and diarrhea can dehydrate you, Zepbound’s patient guide warns. Thirst, a dry mouth, a headache and darker urine are milder signs; dizziness and listlessness are severe ones, MedlinePlus says.

  • Low blood sugar

    With insulin or a sulfonylurea, lows are likelier, the labels say. Weakness or feeling tired is one of their signs, MedlinePlus says.

  • Low blood pressure

    In SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 1.6% of people on Zepbound had low blood pressure, versus 0.1% on placebo. It was more common in people also taking blood pressure medicines (2.2% vs 1.2%), and it also occurred with stomach side effects and dehydration. Compounded tirzepatide wasn’t studied.

  • Nausea

    Stomach side effects are tirzepatide’s most common, and feeling sick can make it hard to eat or drink enough. They’re likeliest while the dose rises.

  • Your mood

    New or worsening depression deserves a call. The FDA asks people on GLP-1 medicines to tell their health care professional about it, though its review of 91 trials found no increased risk of suicidal thoughts.

“Tell your health care professional if you experience new or worsening depression, suicidal thoughts, or any unusual changes in mood or behavior.”

U.S. Food and Drug Administration, FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications, January 13, 2026

Not always the medicine. Tiredness has many causes. If it’s new, heavy or won’t lift, your provider can look for others.

Blood sugar

Could being tired on tirzepatide mean low blood sugar?

It can, if you take insulin or a sulfonylurea. Weakness or feeling tired is a sign of low blood sugar, and tirzepatide makes lows likelier with those medicines.

“Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin”

Eli Lilly and Company, Mounjaro prescribing information, section 5.3, revised August 2026
Glucose below 54 mg/dL, from the Mounjaro and Zepbound prescribing information (revised August 2026). SURPASS-1 (2021) and SURPASS-5 (2022) ran 40 weeks, SURMOUNT-1 (2022) and SURMOUNT-2 (2023) 72 weeks; SURMOUNT-1 didn’t track lows systematically. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.
What else you takeLows on tirzepatideLows on placebo
Nothing else for diabetesMounjaro, SURPASS-1 (2021)0% at every dose1%
Basal insulinMounjaro, SURPASS-5 (2022)14% to 19%13%
Type 2 diabetes, in a weight trialZepbound, SURMOUNT-2 (2023)4.2%1.3%
No diabetesZepbound, SURMOUNT-1 (2022)0.3%None

Swipe the table sideways to see every column.

Glucose below 54 mg/dL, from the Mounjaro and Zepbound prescribing information (revised August 2026). SURPASS-1 (2021) and SURPASS-5 (2022) ran 40 weeks, SURMOUNT-1 (2022) and SURMOUNT-2 (2023) 72 weeks; SURMOUNT-1 didn’t track lows systematically. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.

The signs. Zepbound’s patient guide lists shakiness, sweating, hunger, dizziness, weakness, confusion or drowsiness, a headache and a fast heartbeat, among others. MedlinePlus adds feeling tired.

Check, then treat. If you take insulin or a sulfonylurea, check your blood sugar when you feel this way. Under 70 mg/dL, MedlinePlus says to have about 15 grams of carbohydrate, wait about 15 minutes and check again. If you don’t improve, or someone isn’t alert, get emergency help.

Your other medicines. The labels say a lower dose of insulin or a sulfonylurea may reduce the risk of lows. Only your provider should make that change.

“The risk of hypoglycemia may be lowered by a reduction in the dose of insulin or sulfonylurea (or other concomitantly administered insulin secretagogue).”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026, section 5.7

What helps

What helps with tirzepatide fatigue?

Food, fluids and patience with your dose steps. These tips come from a 2025 advisory of four medical and nutrition societies and Zepbound’s patient guide.

  • Protein at every meal

    Aim for about 80 to 120 grams of protein a day, the advisory suggests. It makes protein a priority to help protect muscle and bone. Have kidney disease? Ask your provider before eating more protein.

  • Small, frequent meals

    When hunger is low, small, frequent meals may work better, and setting a reminder to eat can help, the advisory says.

  • Fluids through the day

    Drinking fluids lowers your chance of dehydration, Zepbound’s patient guide says. Sip more when nausea, vomiting or diarrhea hits.

  • Strength training

    Protein alone likely isn’t enough to keep muscle as you lose weight, the advisory says. It pairs protein with structured strength or resistance training.

  • Patience with dose steps

    If a step leaves you drained, tell your provider before the next increase. They decide whether to hold it or lower your dose.

  • A blood sugar check

    On insulin or a sulfonylurea, check when you feel tired, shaky or foggy, and treat a reading under 70 mg/dL.

Tips from the 2025 joint advisory of the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society, and from Zepbound’s Medication Guide (revised August 2026). More on food: what to eat on a GLP-1.

Step by step

How do you manage tiredness on tirzepatide?

Rule out an emergency, check the usual causes, then talk with your provider. Their instructions come first.

  1. Rule out an emergency. Call 911 if someone is confused, faints, has a seizure or can’t be woken up.
  2. On insulin or a sulfonylurea? Check your blood sugar. Under 70 mg/dL, have about 15 grams of carbohydrate, wait about 15 minutes and check again.
  3. Drink fluids through the day. Sip more when nausea, vomiting or diarrhea hits, and tell your provider right away if they don’t go away.
  4. Eat protein in small, frequent meals. A 2025 advisory suggests about 80 to 120 grams of protein a day. Have kidney disease? Ask your provider first.
  5. Tell your provider before the next dose step. If a step leaves you drained, they decide whether to hold it or lower your dose.
  6. Ask about other causes. Tiredness isn’t always the medicine. If it’s new, heavy or won’t lift, your provider can look for others.

The six steps above, in order. Your label and your provider’s instructions come first.

Vial math

How many units is your tirzepatide dose?

It depends on your vial’s strength. Here are the label’s doses at one example strength, with the fatigue rates its trials reported.

Tirzepatide doses on Zepbound’s label: the share reporting fatigue in SURMOUNT-1 and SURMOUNT-2, and the volume and units on a U-100 syringe at an example strength of 25 mg per mL; your vial’s label decides
DoseFatigue in the trialsmL at 25 mg/mLUnits (U-100)
2.5 mgStarting dose; not reported separately0.1 mL10 units
5 mg5% (placebo: 3%)0.2 mL20 units
7.5 mgStep dose; not reported separately0.3 mL30 units
10 mg6%0.4 mL40 units
12.5 mgStep dose; not reported separately0.5 mL50 units
15 mg7%0.6 mL60 units

The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units. 25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Zepbound’s multi-dose vials come in a strength for each dose, 0.6 mL a dose, so read the strength on your own vial’s label. Your provider sets your dose. Compounded tirzepatide wasn’t studied in these trials. Every step: the tirzepatide dosage chart. Drew more than your dose? Here’s what to do if you took too much tirzepatide. Or enter your own vial’s strength in the tirzepatide dosage calculator.

Warning signs

When is tiredness on tirzepatide a warning sign?

When it comes with other symptoms. These need a call to your provider right away, and a few need 911.

Call 911 if someone is confused, faints, has a seizure or can’t be woken up, or for trouble breathing or swallowing, or swelling of the face, lips, tongue or throat.

From Zepbound’s Medication Guide (revised August 2026), MedlinePlus (dehydration, nausea and vomiting, and low blood sugar) and the FDA (January 13, 2026). If your provider tells you something different, follow their instructions.
Tired, plus…It can be a sign ofWhat to do
Vomiting or diarrhea that won’t stopor no fluids kept down for 12 hoursDehydration, which can lead to kidney problemsTell your provider right away, or get care
Very dark urine or almost none, dizziness or a racing heartSevere dehydrationGet care now
Shakiness, sweating, hunger or foggy thinkingif you take insulin or a sulfonylureaLow blood sugarCheck your level; below 70 mg/dL, eat 15 grams of carbohydrate, then recheck after 15 minutes
Severe belly pain that won’t go awayit may reach your backPancreatitisStop tirzepatide and call your provider right away
Yellow skin or eyes, fever, upper belly pain or clay-colored stoolsA gallbladder problemTell your provider right away
Feeling down, hopeless or not like yourselfDepression or a mood changeTell your provider; call or text 988 if you’re in distress

Swipe the table sideways to see every column.

From Zepbound’s Medication Guide (revised August 2026), MedlinePlus (dehydration, nausea and vomiting, and low blood sugar) and the FDA (January 13, 2026). If your provider tells you something different, follow their instructions.

Sudden vision loss in one eye? Tired or not, call your provider right away. On Nov. 9, 2026, the FDA warned that GLP-1 medicines, tirzepatide included, may raise the risk of NAION, a rare optic nerve condition that can cause it (FDA). More: tirzepatide and vision loss.

Report it. Side effects can be reported to the FDA at 1-800-FDA-1088.

Cost

What does tirzepatide cost at each dose, and every other way to pay?

At LillyDirect, Zepbound’s price climbs with the dose, from $299 to $449 a month; $449, from 7.5 mg, needs a refill within 45 days, or it’s $499 to $699. Through Medicare’s Bridge, if you qualify, it’s $50. Prices checked November 1, 2026.

A month’s price at each dose. LillyDirect, CMS and Medicare.gov, checked November 1, 2026; a Zepbound month is 28 days. Compounded tirzepatide isn’t FDA-approved and isn’t Zepbound or Mounjaro.
RouteAt 2.5 mgAt 5 mgAt 7.5 mg to 15 mg
Zepbound, LillyDirectKwikPen or vials, self-pay$299$399$449 from 7.5 mg with a refill within 45 days; $499 to $699 if not
Mounjaro, LillyDirectself-pay$499$499$499
Medicare GLP-1 BridgeZepbound KwikPen, Part D, if you qualify$50$50$50
NexLife,compounded tirzepatide, not FDA-approved; 12-month plan$115$115$115
NexLife,compounded tirzepatide, not FDA-approved; month to month$129$129$129

Swipe the table sideways to see every column.

A month’s price at each dose. LillyDirect, CMS and Medicare.gov, checked November 1, 2026; a Zepbound month is 28 days. Compounded tirzepatide isn’t FDA-approved and isn’t Zepbound or Mounjaro.

NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works

Other ways to pay. With commercial insurance that covers it, Zepbound’s savings card can bring a pen to as little as $25 for a 1- to 3-month fill, until December 31, 2026; it isn’t for Medicare or Medicaid. TrumpRx.gov lists Zepbound vials starting at $299, filled through LillyDirect. The Bridge runs through December 31, 2027, with prior authorization, but not for people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease. Online, compounded tirzepatide costs $126 to $599 a month, all in, month to month (median $285 across the 25 programs that publish a month-to-month price in our GLP-1 price index, checked Nov. 4, 2026).

If your provider holds your dose, what you pay at LillyDirect depends on the step you’re on. At NexLife, compounded tirzepatide, which isn’t FDA-approved, costs the same at every dose: $1,380 a year on the 12-month plan, or $1,548 month to month, against $5,837 for 13 four-week fills of Zepbound at $449, its price from 7.5 mg with a refill within 45 days (or it’s $499 to $699). Paying less elsewhere for compounded tirzepatide? Our Price Match Guarantee† matches your regular monthly price. More: Zepbound’s cost without insurance.

Have type 2 diabetes? NexLife’s providers prescribe compounded tirzepatide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace Mounjaro or your diabetes care.

At NexLife

Tired on tirzepatide at NexLife: who helps, and what it costs

Care and access, not a promise of more energy: anyone on tirzepatide can feel tired. Here’s who helps.

  1. A provider who adjusts with you

    Your licensed provider follows your dose. If tiredness or another side effect makes a step hard, they decide whether to hold it or lower your dose.

  2. The same price, whatever your dose

    $115 a month on the 12-month plan, $119 on 6 months, $125 on 3 months or $129 month to month. Holding or lowering a dose doesn’t change it, and there’s no membership fee. Compounded tirzepatide isn’t FDA-approved, isn’t Zepbound or Mounjaro, and a licensed provider prescribes it only when it offers a significant difference for you.

  3. Food help built in

    Every plan includes a nutrition plan and a 1:1 coaching call, for the weeks when eating enough is hard.

  4. Real people, any time

    Call or text (949) 818-8000. Real people answer 24/7, and physicians answer medical questions during clinical hours. For an emergency, call 911.

  5. A named medical director

    NexLife’s medical director is Adam Kennah, MD (NPI 1144260043), board-certified in emergency medicine by the American Board of Emergency Medicine.

  6. The pharmacy, handled

    One of our two state-licensed 503A partner pharmacies, Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA), fills your prescription and ships it free. If something seems off with your vial or delivery, tell us and we follow up.

  7. Ways to pay

    An HSA or FSA card, with a letter of medical necessity from us, or Affirm, Klarna or Afterpay at checkout. People with Medicare can pay for themselves; if you qualify for the $50 Bridge, it may cost you less. Not prescribed? No charge for medication.

On Trustpilot, NexLife is rated 4.8 out of 5 from 407 reviews (read November 1, 2026), and it’s LegitScript-certified.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $129/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan; $109/mo month to month.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Tirzepatide and tiredness: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

How long does tirzepatide fatigue last?

The labels don’t give a timeline. Side effects tend to come early and with each dose increase, then ease on a steady dose, a 2025 advisory says, and doses rise no faster than every 4 weeks. If tiredness doesn’t lift after a few weeks on the same dose, tell your provider.

What helps with tiredness on tirzepatide?

Food, fluids and time. A 2025 advisory suggests 80 to 120 grams of protein a day (have kidney disease? ask first) and small, frequent meals when hunger is low, and Zepbound’s patient guide says fluids help prevent dehydration. Strength training helps protect muscle. If a dose step leaves you drained, your provider can hold it.

Does tirzepatide make you tired?

Sometimes: in SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 5% to 7% of people on Zepbound reported fatigue, versus 3% on placebo, its August 2026 label says. Compounded tirzepatide wasn’t studied. Eating much less, losing fluids and, with insulin or a sulfonylurea, low blood sugar can add to it.

Why am I so tired on Zepbound?

Check the basics first: eating much less, too few fluids, or a dose that just went up. With insulin or a sulfonylurea, low blood sugar is a possibility, and low blood pressure is a less common one. Check food, fluids and, if you need to, your blood sugar, then tell your provider.

Does Mounjaro cause fatigue?

It can. Mounjaro’s August 2026 label lists fatigue in 10% of 6,647 adults in SURPASS-CVOT (2025), its heart-outcomes trial against dulaglutide, though not among the common side effects of its placebo-controlled diabetes trials. Those trials studied FDA-approved Mounjaro; compounded tirzepatide wasn’t studied.

Does a higher dose of tirzepatide make you more tired?

A little, in Zepbound’s trials: fatigue was reported by 5% on 5 mg, 6% on 10 mg and 7% on 15 mg, versus 3% on placebo (SURMOUNT-1, 2022, and SURMOUNT-2, 2023). These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied. Your provider decides your dose.

Can low blood sugar on tirzepatide make you tired?

Yes. Weakness or feeling tired is a sign of low blood sugar, MedlinePlus says, and lows are likelier when tirzepatide is taken with insulin or a sulfonylurea. If you take those, check your level when you feel off; under 70 mg/dL, have 15 grams of carbohydrate and recheck in 15 minutes.

When should I call a doctor about tiredness on tirzepatide?

Call 911 for confusion, fainting, a seizure or someone who can’t be woken, or a low blood sugar that doesn’t improve after sugar. For severe belly pain that won’t go away, stop tirzepatide and call your provider right away. Call right away, too, if tiredness comes with vomiting or diarrhea that won’t stop, or yellow skin or eyes.

Does compounded tirzepatide cause fatigue?

No one knows its exact rate: compounded tirzepatide isn’t FDA-approved and wasn’t studied in Zepbound’s or Mounjaro’s trials. Fatigue is a listed side effect of FDA-approved tirzepatide, so treat tiredness the same way and tell your provider. At NexLife, call or text (949) 818-8000, 24/7.

Is feeling dizzy and tired on tirzepatide a sign of low blood pressure?

It can be. In Zepbound’s trials, SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 1.6% had low blood pressure, versus 0.1% on placebo. It was more common with blood pressure medicines (2.2% vs 1.2%) and also occurred with stomach side effects and dehydration. Compounded tirzepatide wasn’t studied. Dizziness can also mean low blood sugar or fluid loss, so tell your provider.

Should I lower my tirzepatide dose if I feel tired?

Not on your own. If tiredness doesn’t ease after a few weeks on the same dose, or it gets in the way of your day, tell your provider. They decide whether to hold a step or lower your dose; Zepbound’s label says a lower maintenance dose can be considered if one isn’t tolerated.

Does tirzepatide cause weakness or lethargy?

It can. Zepbound’s label counts weakness (asthenia), fatigue, lethargy and malaise together as fatigue, and 5% to 7% of people on Zepbound reported it, versus 3% on placebo, in SURMOUNT-1 (2022) and SURMOUNT-2 (2023). Compounded tirzepatide wasn’t studied in these trials.

Can eating too little on tirzepatide make you tired?

It can. GLP-1 medicines cut how much people eat by 16% to 39% compared with placebo, a 2025 advisory says. Below about 1,200 calories a day for women or 1,800 for men, vitamins and minerals can fall short, and tiredness beyond what you’d expect can signal a shortfall. When hunger is low, small, frequent meals may work better.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Checked every label figure, symptom list and price against its source on November 1, 2026.

  • How we checked. Fatigue rates, the dose steps, and the low blood sugar and blood pressure figures come from the Zepbound and Mounjaro prescribing information (both revised August 2026) and Zepbound’s Medication Guide, read on November 1, 2026. Eating tips come from a 2025 joint advisory of four medical and nutrition societies, symptom guidance from MedlinePlus, mood guidance from the FDA, and prices from LillyDirect, TrumpRx.gov, CMS and Medicare.gov, all read the same day. We don’t give a dosing plan: your provider decides. Zepbound, Mounjaro, KwikPen and LillyDirect are trademarks of Eli Lilly and Company. NexLife isn’t affiliated with Eli Lilly and Company.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
  • How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves

Paying less elsewhere? We match it.†

Feeling run down? Real people answer 24/7.

Start with a 3-minute online check. A licensed provider decides if compounded tirzepatide is right for you, and the price is the same at every dose: $115 a month on the 12-month plan, or $129 month to month.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 1, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Zepbound (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
  2. Zepbound Medication Guide, Eli Lilly (revised August 2026). Read November 1, 2026.
  3. Mounjaro (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
  4. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity, 2025;33(8):1475-1503. Read November 1, 2026.
  5. MedlinePlus: Low blood sugar, self-care (reviewed January 25, 2026). Read November 1, 2026.
  6. MedlinePlus: Low blood sugar (reviewed January 25, 2026). Read November 1, 2026.
  7. MedlinePlus: Dehydration (reviewed July 1, 2025). Read November 1, 2026.
  8. MedlinePlus: Nausea and vomiting, adults (reviewed July 22, 2025). Read November 1, 2026.
  9. FDA Drug Safety Communication on GLP-1 medicines and suicidal thoughts (January 13, 2026). Read November 1, 2026.
  10. Eli Lilly: Zepbound dosing, for healthcare professionals (names SURMOUNT-1 and SURMOUNT-2). Read November 1, 2026.
  11. SURMOUNT-2: Garvey WT, et al. The Lancet 2023;402:613-26. Citation checked October 25, 2026.
  12. SURPASS-1: Rosenstock J, et al. The Lancet 2021;398:143-55 (American College of Cardiology trial summary). Read November 1, 2026.
  13. SURPASS-5: Dahl D, et al. JAMA 2022;327(6):534-545. Read October 25, 2026.
  14. SURPASS-CVOT: Nicholls SJ, et al. N Engl J Med 2025;393(24):2409-2420 (Lilly’s cardiovascular outcomes page). Read November 1, 2026.
  15. LillyDirect: Zepbound self-pay prices. Checked November 1, 2026.
  16. LillyDirect: Mounjaro self-pay prices. Checked November 1, 2026.
  17. Eli Lilly: Zepbound savings card terms. Checked November 1, 2026.
  18. TrumpRx.gov: Zepbound vial. Checked November 1, 2026.
  19. CMS: Medicare GLP-1 Bridge. Checked November 1, 2026.
  20. Medicare.gov: Weight loss drugs (the GLP-1 Bridge). Checked November 1, 2026.
  21. NexLife: GLP-1 price index. Compounded prices checked November 1, 2026.
  22. NexLife: pricing, every plan.